Palatin Technologies PTN
NASDAQ PTN
$9.88 -0.56 (-5.41%)
As of: Aug 21, 2026 · 3:59 PM EDT

Palatin Technologies (PTN) Debt Ratio (2015 - 2024)

Palatin Technologies' (PTN) quarterly Debt Ratio came in at 0.24 in Q4 2024, up 193.35% YoY from 0.08 in Q1 2024, and down 26.09% on a QoQ basis from 0.32 in Q3 2024.

Palatin Technologies (PTN) Debt Ratio (2015 - 2024) Analysis & Trends

Palatin Technologies (PTN) has 7 years of Debt Ratio data on file, last reported at 0.24 in Q4 2024.

  • Quarterly Debt Ratio rose 193.35% year-over-year to 0.24 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 0.24 (up 193.35% YoY) and the FY2024 annual result came in at 0.1, down 17.25% from the prior year.
  • Debt Ratio declined to 0.24 in Q4 2024, from 0.32 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.32 in Q3 2024 to a low of 0.08 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 0.05
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 0.05
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 0.12
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 0.03
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 0.26
9 Royalty Pharma 27.27 Bn 26.43 Bn - 0.47
10 Palatin Technologies 40.37 Mn 40.37 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 0.24
Sep 30, 2024 0.32
Jun 30, 2024 0.10
Mar 31, 2024 0.09
Dec 31, 2023 0.08
Jun 30, 2023 0.12
Jun 30, 2019 0.00
Mar 31, 2019 0.06
Dec 31, 2018 0.09
Sep 30, 2018 0.13
Jun 30, 2018 0.01
Mar 31, 2018 0.05
Dec 31, 2017 0.28
Sep 30, 2017 0.24
Jun 30, 2017 0.11
Mar 31, 2017 0.26
Dec 31, 2016 0.71
Sep 30, 2016 1.07
Jun 30, 2016 1.30
Jun 30, 2015 0.33